GlassScriptPhysician profile
Safia Pirani
NPI 1871589572
$888.22
in general payments reported to CMS, 2019-2025
20 companies · $70.10 in 2025
The $70.10 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.05 · 2020: $321 · 2021: $129 · 2022: $79.82 · 2023: $170 · 2024: $83.05 · 2025: $70.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $130.41 | 2019-2025 | |
| Optinose US, INC. | $85.13 | 2021-2023 | |
| Glaxosmithkline, LLC. | $83.59 | 2020-2023 | Shingrix |
| Lilly USA, LLC | $68.95 | 2020-2024 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $68.47 | 2020 | |
| Topcon Healthcare Solutions, INC. | $64.90 | 2020 | |
| Novo Nordisk INC | $64.13 | 2020-2021 | |
| Exact Sciences Corporation | $57.10 | 2023-2024 | Cologuard Collection Kit |
| Abbott Laboratories | $43.80 | 2024-2025 | Proclaim |
| Dexcom, INC. | $35.84 | 2022-2025 | Dexcom G6 Transmitter |
| Horizon Therapeutics Plc | $24.86 | 2022 | |
| Linus Health, INC. | $24.38 | 2023-2024 | Core Cognitive Evaluation |
| Vbi Vaccine (Delaware) INC. | $23.60 | 2023 | Prehevbrio |
| Janssen Pharmaceuticals, INC | $21.79 | 2020 | |
| Mylan Specialty L.P. | $19.75 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.67 | 2020 | |
| Sanofi Pasteur INC. | $17.00 | 2023 | |
| Bioventus LLC | $13.73 | 2021 | |
| Paratek Pharmaceuticals, INC. | $11.85 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Safia Pirani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.